aspirin may selectively and potently inhibit colon cancer recurrence and improve survival in patient tumors with PI3KCA mutations. While this finding is compelling
aspirin may selectively and potently inhibit colon cancerrecurrence and improve survival in patient tumors with PI3KCA mutations. While thisfinding is compelling